Back
Goldman Sachs Nasdaq-100 Core Prm IncETF Vs. Avidity Biosciences Industry Stock Comparison
Buy
55
GPIQ
Goldman Sachs Nasdaq-100 Core Prm IncETF
Last Price:
48.13
Seasonality Move:
9.22%
Sell
28
RNA
Avidity Biosciences
Last Price:
42.16
Seasonality Move:
39.98%
Buy
55
Goldman Sachs Nasdaq-100 Core Prm IncETF (GPIQ)
is a Buy
Is Goldman Sachs Nasdaq-100 Core Prm IncETF a Buy, Sell or Hold?
- The current Goldman Sachs Nasdaq-100 Core Prm IncETF [GPIQ] share price is $48.12. The Score for GPIQ is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- GPIQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPIQ Stock Price Chart
What is Goldman Sachs Nasdaq-100 Core Prm IncETF's stock price today?
-
The Goldman Sachs Nasdaq-100 Core Prm IncETF share price today is $48.12
The current trend is moderately bearish and GPIQ is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $42.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
GPIQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 48.05 | Sell |
| Chaikin Money Flow: | -100242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.65 - 48.97) | Sell |
| Bollinger Bands (100): | (45.82 - 48.62) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 42.17 | Sell |
| Chaikin Money Flow: | -1839481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.78 - 48.76) | Sell |
| Bollinger Bands (100): | (41.56 - 46.96) | Sell |
GPIQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.1 | Sell |
| 20-day SMA: | 48.4 | Sell |
| 50-day SMA: | 47.7 | Buy |
| 200-day SMA: | 46.63 | Buy |
| 8-day EMA: | 48.79 | Sell |
| 20-day EMA: | 48.47 | Sell |
| 50-day EMA: | 47.87 | Buy |
| 200-day EMA: | 46.34 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.51 | Sell |
| 20-day SMA: | 45.87 | Sell |
| 50-day SMA: | 45.1 | Sell |
| 200-day SMA: | 34.2 | Buy |
| 8-day EMA: | 46.84 | Sell |
| 20-day EMA: | 46.32 | Sell |
| 50-day EMA: | 45.24 | Sell |
| 200-day EMA: | 35.58 | Buy |
Goldman Sachs Nasdaq-100 Core Prm IncETF Earnings Growth & GPIQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.24 per share.
Goldman Sachs Nasdaq-100 Core Prm IncETF Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||